Other dosage forms:
As well as its needed effects, methylprednisolone (the active ingredient contained in Solu-Medrol) may cause unwanted side effects that require medical attention.
If any of the following side effects occur while taking methylprednisolone, check with your doctor immediately:
Some methylprednisolone side effects may not need any medical attention.
As your body gets used to the medicine these side effects may disappear.
Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
The most commonly occurring side effects have included fluid retention, alteration in glucose tolerance, increased blood pressure, behavioral and mood changes, increased appetite, and weight gain; the incidence generally correlates with dosage, timing of administration, and duration of treatment.
Frequency not reported: Allergic or hypersensitivity reactions; anaphylactoid reaction, anaphylaxis, angioedema
Frequency not reported: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis, edema, hypotension
Frequency not reported: Cushingoid state, hirsutism, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery, or illness), moon face
Frequency not reported: Abdominal distention, nausea, pancreatitis, peptic ulcer, perforation of the small and large intestine, ulcerative esophagitis, gastric hemorrhage, vomiting, abdominal pain, diarrhea, dyspepsia, nausea
Frequency not reported: Hepatomegaly, elevation in liver enzymes, toxic hepatitis
Reversible transaminase elevations (AST, ALT) have been observed following corticosteroid therapy.
These changes have generally been small and not associated with any clinical syndrome.
Toxic hepatitis has been reported with high doses of cyclically pulsed IV therapy, onset has been several weeks or longer.
Resolution has been reported with discontinuation; however, recurrence has been reported with rechallenge.
Frequency not reported: Decreased carbohydrate and glucose tolerance, manifestations of latent diabetes, hypokalemic alkalosis, potassium loss, sodium retention, increased appetite, negative nitrogen balance due to protein catabolism, weight gain, metabolic acidosis, dyslipidemia, lipomatosis
Frequency not reported: Suppression of growth in pediatric patients, aseptic necrosis of femoral and humeral heads, calcinosis, Charcot-like atrophy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, postinjection flare, steroid myopathy, tendon rupture, particularly of the Achilles tendon, vertebral compression fractures, myalgia, muscle atrophy, osteonecrosis, neuropathic arthralgia, growth retardation
Frequency not reported: Leucocytosis
Frequency not reported: Opportunistic infection
Blindness has been reported with corticosteroid injection to scalp, tonsillar fauces, sphenopalatine ganglion.
Frequency not reported: Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, blindness, chorioretinopathy
Frequency not reported: Depression, emotional instability, euphoria, insomnia, mood swings, personality changes, psychic disorders, confusional states, anxiety, abnormal behavior, irritability
Frequency not reported: Acne, allergic dermatitis, cutaneous and subcutaneous atrophy, dry scaly skin, ecchymosis, petechiae, erythema, hyperpigmentation, hypopigmentation, impaired wound healing, increased sweating, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria, hypertrichosis, angioedema, skin atrophy, hyperhidrosis, pruritus
Frequency not reported: Injection site infections, injection site reactions
Frequency not reported: Convulsions, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, neuritis, neuropathy, paresthesia, amnesia, dizziness
Frequency not reported: Vertigo, abnormal fat deposits, malaise, sterile abscess, impaired healing, fatigue
Frequency not reported: Kaposi's sarcoma
Frequency not reported: Pulmonary edema, pulmonary embolism, hiccups
Frequency not reported: Menstrual irregularities, increased or decreased motility and number of spermatozoa, increased urine calcium, glycosuria
It is possible that some side effects of Solu-Medrol may not have been reported.
These can be reported to the FDA here.
Always consult a healthcare professional for medical advice.
injection powder for solution, injection suspension
Aggression
agitation
anxiety
blurred vision
decrease in the amount of urine
dizziness
fast, slow, pounding, or irregular heartbeat or pulse
headache
irritability
mental depression
mood changes
nervousness
noisy, rattling breathing
numbness or tingling in the arms or legs
pounding in the ears
shortness of breath
swelling of the fingers, hands, feet, or lower legs
trouble thinking, speaking, or walking
troubled breathing at rest
weight gain
Abdominal cramping and/or burning (severe)
abdominal pain
backache
bloody, black, or tarry stools
cough or hoarseness
darkening of skin
decrease in height
decreased vision
diarrhea
dry mouth
eye pain
eye tearing
facial hair growth in females
fainting
fatigue
fever or chills
flushed, dry skin
fractures
fruit-like breath odor
full or round face, neck, or trunk
heartburn and/or indigestion (severe and continuous)
increased hunger
increased thirst
increased urination
loss of appetite
loss of sexual desire or ability
lower back or side pain
menstrual irregularities
muscle pain or tenderness
muscle wasting or weakness
nausea
pain in back, ribs, arms, or legs
painful or difficult urination
skin rash
sleeplessness
sweating
trouble healing
trouble sleeping
unexplained weight loss
unusual tiredness or weakness
vision changes
vomiting
vomiting of material that looks like coffee grounds
Increased appetite
Abnormal fat deposits on the face, neck, and trunk
acne
dry scalp
lightening of normal skin color
red face
reddish purple lines on the arms, face, legs, trunk, or groin
swelling of the stomach area
thinning of the scalp hair